awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35791125-FAAFA9C5-72FA-4190-AE3B-9CF7CD70588D
Q35791125-FAAFA9C5-72FA-4190-AE3B-9CF7CD70588D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35791125-FAAFA9C5-72FA-4190-AE3B-9CF7CD70588D
Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults
P2860
Q35791125-FAAFA9C5-72FA-4190-AE3B-9CF7CD70588D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35791125-FAAFA9C5-72FA-4190-AE3B-9CF7CD70588D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5c0bd37477d046937f876017511a73fb9b6a61d5
P2860
Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes.